Innovative, long-acting treatments – for patients and society
Camurus is committed to improving the lives of patients with severe and chronic diseases
Learn moreUpdates
Latest news
Disease areas
Focus on severe and chronic diseases
Developing treatments for diseases within the central nervous system, rare diseases, endocrinology, oncology and supportive care.
Events
Upcoming events
-
09Nov
BIO Europe 2026
Camurus will participate in this conference in Cologne, Germany, 9-11 November, 2026.
-
11Nov
Stifel Healthcare Conference
Camurus’ Chief Business Development Officer Fredrik Joabsson is presenting at this conference in New York at 7.20pm CET. The presentation can be seen by the conference participants.
-
18Nov
Jefferies Global Healthcare Conference London
Camurus’ President & CEO Fredrik Tiberg is presenting at this conference in London, at 10.00am CET. Access the webcast using this link: Webcast
Latest financial report
Camurus’ Interim Report Third Quarter 2026
5 November 2026
Annual Report 2025
Pipeline
Diversified pipeline with large potential
Camurus’ innovative product candidates are designed to address important unmet medical needs, with the potential to make significant difference in the daily life of patients by improving treatment outcomes, quality of life, and long-term recovery.
Sustainability
Our approach to sustainability
Ensuring the long-term successful development of our business – for the benefit of patients, healthcare systems, employees and shareholders.
